Table 3 Chart review results-- patient characteristics and prognosis documentation in the intervention and control groups
Intervention | Control | P-value | ||
|---|---|---|---|---|
Patient characteristics | ||||
Number of patients involved in reviewed charts | N = 49 | N = 63 | ||
Patient age, mean (SD), year | 68.9 (7.7) | 70.0 (8.3) | 0.58 | |
Female patient, number (%) | 23 (47 %) | 42 (67 %) | 0.05 | |
Patient race, number (%) | ||||
- White | 31 (63 %) | 2 (3 %) | <0.001 | |
- African American | 12 (24 %) | 56 (89 %) | <0.001 | |
- Other | 6 (12 %) | 5 (8 %) | 0.53 | |
Number of chronic conditions a, mean (SD) | 4.0 (1.7) | 3.3 (1.4) | 0.02 | |
Number of medications, mean (SD) | 11.1 (5.9) | 10.4 (6.0) | 0.52 | |
Documentation results | ||||
Number of charts reviewed | N = 71 (baseline 25, follow-up 46) | N = 71 (baseline 25, follow-up 46) | ||
Overall prognosis | Baseline | 1/25 | 0/25 | >0.99 |
Follow-up | 8/46 | 0/46 | 0.006 | |
Cancer screening | Baseline | 15/25 | 13/25 | 0.78 |
Follow-up | 17/46 | 26/46 | 0.09 | |
Overall prognosis documentation among charts that documented cancer screening | Baseline | 0/15 | 0/13 | >0.99 |
Follow-up | 3/17 | 0/26 | 0.06 | |